244460 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
OliPass Corp. develops biological products. It offers artificial gene and gene therapy. The company was founded by Shin Chung on November 16, 2006 and is headquartered in Yongin, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
244460 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company